Assuming that that there are too many things that

Assuming that that there are too many things that have to go right, competition is too intense, and timing of patent award is too late for NNLX to prosper from a Covid test - my question is - will they still have “ bigger fish to fry” if all these other competing tests are developed to test Covid? In other words, it only seems logical that those tests could be configured to go after markets that NNLX is focused on? My concern is that NNLX will have lots of competition now that all of these educational institutions and pharmaceutical companies see big dollars to be made in developing different types of tests - my hope is that NNLX still has superior technology and there is a market for it!